Found 10 matching trials
Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab
PHASE2The purpose of the study is to find out if an investigational drug called D...
Location
Moffitt Cancer Center
Trial With Autologous Dendritic Cell Vaccination in Patients With Stage II-III HER2 Negative Breast Cancer
PHASE2Molecular expression in breast cancer (BC) defines special fenotypes with d...
Location
ClΓnica Universidad de Navarra
DC Vaccine for Patients With Ductal Carcinoma In Situ
PHASE1Women who are diagnosed with Her-2/neu over-expressing DCIS will receive DC...
Location
Hospital of the University of Pennsylvania
Trial of Therapies With IT cDC1s Combined w/ IT Trastuzamab for Her+ or IT Nivolumab for Her- BC LMD
PHASE2The purpose of this study is to learn about the effects of the study treatm...
Location
Moffitt Cancer Center
A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV)
PHASE1The purpose of this study is to learn about the effects of the study treatm...
Status
Active Not Recruiting
Location
Moffitt Cancer Center
Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
PHASE2RATIONALE: Vaccines made from a person's white blood cells may help the bod...
Location
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
Adoptive T Cell Therapy Following HER2-Pulsed Dendritic Cell Vaccine & Pepinemab /Trastuzumab in Patients w/ Metastatic HER2+ Breast Cancer
PHASE1The purpose of this study is to test the safety of Adoptive T-Cell therapy ...
Location
Moffitt Cancer Center
HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast Cancer
PHASE1The purpose of this study is to determine the safety and immunogenicity of ...
Location
H. Lee Moffitt Cancer Center and Research Institute
Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Ductal Carcinoma In Situ of the Breast
PHASE1RATIONALE: Vaccines made from peptides and a person's white blood cells may...
Location
Abramson Cancer Center of the University of Pennsylvania
HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast Cancer Post Neoadjuvant Chemotherapy
PHASE1The primary goals of this trial will be to determine the safety and immune ...
Location
H. Lee Moffitt Cancer Center and Research Institute